CDC Panel Recommends RSV Vaccine for Older Adults 60+

An advisory committee for the Centers for Disease Control and Prevention (CDC) has recommended RSV vaccines for older adults after reviewing clinical trial data for two vaccines by Pfizer and GSK. The vaccines have already received approval from the U.S. Food and Drug Administration. The committee said adults aged 60 and over may get the vaccines based on individual needs and after consultation with a doctor. RSV can affect people of all ages, though some age groups are at higher risk, including adults aged 65 and older. Between 60,000 to 160,000 older adults in the U.S. are hospitalized due to RSV every year and 6,000 to 10,000 of them die, the CDC said.